Testing a plant-based diet and its effects on gut bacteria and bile acids
Tests a more plant-based, less animal-based diet in adults with colorectal adenoma.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 18 Jun 2026
- Expected to end
- 1 Jun 2028
- Type of study
- Interventional
- Treatments tested
- Increased Plant-Based Diet and Decreased Animal-Based Diet
- Record updated
- 23 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-80 who had at least one adenoma removed during a colonoscopy and who usually eat a Western-style diet. They will eat more plant-based and less animal-based food.
- Age
- 18-80 years
- Sex
- All sexes can join.
- Disease stage
- Had a screening or surveillance colonoscopy with at least one adenoma removed. BMI at least 18.5 kg/m2 but less than 35 kg/m2.
- Earlier treatment
- Must not have used antibiotics or probiotics. Must not use aspirin regularly. Must not be on anticoagulant (blood thinner) drugs unless willing and able to stop them. Weight stable in the last 3 months (loss or gain under 4%).
Main reasons for not taking part
- Strict diet such as vegan, carnivore, kosher or low-carb
- Inflammatory bowel disease, liver or kidney disease, or bleeding disorder
- Earlier gastrointestinal cancer, or other cancer treated in the last three years (except nonmelanoma skin cancer)
- Familial Adenomatous Polyposis or Lynch Syndrome
- Pregnant or breastfeeding, or known HIV, hepatitis C or hepatitis B infection
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Underwent screening or surveillance colonoscopy with removal of at least one adenoma
- Age 18-80 years
- Habitually consume a Western pattern diet
- BMI of at least 18.5 kg/m2 but less than 35 kg/m2
- Weight stable in last 3 months (loss or gain <4%)
- Subjects must be able and willing to follow study procedures and instructions
- Ability to understand and the willingness to sign a written informed consent document
Who cannot take part
- Any prior diagnosis of gastrointestinal cancer (including esophageal, small intestine, colon, pancreatic), or any diagnosis of other cancers (with the exception of nonmelanoma skin) in which there has been any active treatment within the last three years
- Any adenoma that was not completely removed during previous colonoscopy
- Participants who are receiving any other investigational agents
- Diagnosis of inflammatory bowel disease, liver or kidney disease, bleeding diathesis
- Known diagnosis of Familial Adenomatous Polyposis (FAP) or Hereditary Non-Polyposis Colorectal Cancer (HNPCC, Lynch Syndrome)
- Known bleeding tendency/condition (e.g. von Willebrand disease) or history of peptic ulcer or gastrointestinal bleed requiring hospitalization, endoscopic complications, or contraindication to colonoscopy
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
- Known positive test for human immunodeficiency virus (HIV), hepatitis C virus, or acute or chronic hepatitis B infection
- Current use of anticoagulant therapies, including Heparin, Warfarin, Dalteparin sodium, Bivalirudin, Argatroban, Lepirudin, Heparin Sodium, Heparin/Dextrose, and an unwillingness or inability to discontinue anticoagulants
- Strict dietary patterns (e.g., vegan, carnivore, kosher, low-carb etc.)
- Regular use of aspirin
- Use of antibiotics or probiotics
- Inability or unwillingness to abstain from limited consumption of animal-based food or to provide blood or stool samples during the study
- Pregnant or breastfeeding
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- Massachusetts General Hospital Cancer CenterBoston, United StatesContact: Andrew T. Chan, MD, MPHTaking people
About the trial
What the trial wants to find out
This research study is a prospective, single-arm clinical trial to assess the effect of a dietary intervention for more plant-based and less animal-based food intake on secondary bile acid production, gut microbiota, circulating biomarkers and gene expression associated with colonic bile acid receptor activation and colorectal cancer.
The group in the trial
- Increased Plant-Based Diet and Decreased Animal-Based DietTreatment being tested
Participants will be instructed to self-regulate their diet by increasing the amount of plant-based foods while decreasing the amount of animal-based foods for a 4-week period.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- BILMOD: BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
- Plain-language title
- Testing a plant-based diet and its effects on gut bacteria and bile acidsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07162337, who can take part
- Record updated
- 23 June 2026